Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the successful completion of its acquisition of Kindred at Home (KAH), the nation's largest home health and hospice provider. With the addition of Kindred at Home, Humana is now the nation's largest provider of care in the home, significantly strengthening its ability to provide high-quality, whole-person healthcare that can improve patient health outcomes on a much broader scale. Humana is committed to delivering excelle

Humana Completes Acquisition of Kindred at Home

Humana share price has taken a downward spiral of late. Long-term prospects appear good, and there remains room for significant share price growth in the medium to longer term.

Humana: A Strong Buy The Dip

In trading on Thursday, shares of Humana entered into oversold territory, hitting an RSI reading of 29.1

Oversold Conditions For Humana

Applied Materials

Activision Blizzard

Bank of New York Mellon

Cintas Corp

Domino's Pizza

Goldman Sachs

Home Depot

Intercontinental Exchange

JPMorgan Chase & Co

Lockheed Martin

Lowe's

Lam Research

Mastercard

MarketAxess Holdings

Morgan Stanley

Northrop Grumman

Northern Trust

Roper Technologies

Charles Schwab

Sherwin-Williams

SS&C Technologies Hlds

Thermo Fisher Scientific

T. Rowe Price Group

Tractor Supply

Texas Instruments

UnitedHealth Group

Visa

ViacomCBS

I present 30 High Growth Dividend Stocks for consideration in August 2021. There are 4 new stocks on this month's watchlist, 3 with dividend yields above 2%.

High Growth Dividend Stocks For August 2021

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana highlights commitment to addressing health equity in 2020 corporate responsibility report

Humana Highlights Commitment to Addressing Health Equity in 2020 Corporate Responsibility Report

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $3.0 billion in senior notes. These senior notes are comprised of $1,500 million of the company's 0.650 percent senior notes, due 2023 (the “2023 notes”), at 99.933 percent of the principal amount, $750 million of the company's 1.350 percent senior notes, due 2027 (the “2027 notes”), at 99.905 percent of the principal amount and $750 million of the company's 2.150 p

Humana Completes Aggregate $3.0 Billion Debt Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it is promoting health care industry veteran Sue Schick to President of the company's Group, Military and Specialty businesses, effective September 1, 2021. Schick came to Humana at the beginning of 2020 to join the segment's leadership team, with oversight of employer group sales and market operations. “From the day Sue arrived at Humana, the Management Team and I have been impr

Humana's Sue Schick Appointed President of Company's Group, Military and Specialty Businesses

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $3.0 billion in senior notes. These senior notes are comprised of $1,500 million of the company's 0.650 percent senior notes, due 2023 (the “2023 notes”), at 99.933 percent of the principal amount, $750 million of the company's 1.350 percent senior notes, due 2027 (the “2027 notes”), at 99.905 percent of the principal amount and $750 million of the company's 2.150 pe

Humana Prices $3.0 Billion Debt Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study

Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study

Humana Inc. (HUM) CEO Bruce Broussard on Q2 2021 Results - Earnings Call Transcript

Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.

Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y

Humana (HUM) delivered earnings and revenue surprises of 0.44% and 0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Q2 Earnings and Revenues Surpass Estimates

Shares of Humana (NYSE:HUM) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 45.14% over the past year to $6.89, which beat the estimate of $6.82.

Recap: Humana Q2 Earnings

Humana Inc. reported second-quarter profit and revenue that beat expectations, but maintained its full-year adjusted earnings outlook, while saying it expects to record a $1 billion gain in the current quarter on its ownership of Kindred at Home. The health insurer said pretax net income fell to $738 million, or $4.55 a share, from $2.59 billion, or $13.75 a share, in the year-ago period, citing the "significant, temporary deferral of care in 2020" from COVID-19-related factors.

Humana beats profit and revenue expectations, maintains full-year adjusted earnings outlook

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax income and diluted earnings per common share for the quarter ended June 30, 2021 (2Q21) versus the quarter ended June 30, 2020 (2Q20) and for the six months ended June 30, 2021 (YTD 2021) versus the six months ended June 30, 2020 (YTD 2020) as noted in the tables below. Consolidated income before income taxes and equity in earnings (pretax income) In millions 2Q21 (a) 2Q20 (b) YTD 2021 (c) YTD 2020 (d)

Humana Reports Second Quarter 2021 Financial Results; Maintains Full Year 2021 Adjusted EPS Financial Guidance

Humana's (HUM) second-quarter earnings results to reflect a steep expense level, partly offset by better revenues.

Humana (HUM) to Announce Q2 Earnings: Here's What to Expect

NASHVILLE, Tenn., July 19, 2021 /PRNewswire/ -- XSOLIS, the company solving operational challenges in healthcare, is partnering with Humana Inc., a leading health and well-being company, to offer its real-time, predictive analytics platform for utilization review processes between Humana and participating providers.

XSOLIS Collaborates with Humana on New Approach to Utilization Management

The stock price of Humana (NYSE: HUM) has seen a 10% rise over the last twenty-one trading days, while it is up 18% over the last year. Humana has benefited from higher Medicare Advantage premium income as well as increased healthcare services revenues.

Will Humana Stock Continue Its Rally After A 10% Rise In A Month?

Humana (HUM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Humana (HUM): Strong Industry, Solid Earnings Estimate Revisions

These are Insider's biggest healthcare stories for July 13.

How Humana fueled primary-care company Iora Health

Humana (HUM) inks a deal with Montefiore Health System to better serve Humana Medicare Advantage members in Bronx, Westchester and Hudson Valley.

Humana (HUM) Joins Montefiore Health for Better Healthcare

LOUISVILLE, Ky.--(BUSINESS WIRE)--Louisville nonprofits receive $1.7 million through The Humana Foundation from the community partners program.

Louisville Nonprofits Receive $1.7 Million through The Humana Foundation's Community Partners Program

Anthem

Joint

Health insurers' second-quarter 2021 earnings results are likely to reflect higher premiums, partly offset by elevated operating costs.

3 Health Insurers Poised to Beat Earnings Estimates in Q2

SAN ANTONIO--(BUSINESS WIRE)--Humana hiring up to 200 virtual, seasonal positions in San Antonio.

Humana Hiring up to 200 Virtual, Seasonal Positions in San Antonio

NEW YORK--(BUSINESS WIRE)--Montefiore Health System and Humana sign multi-year agreement offering in-network coverage for Medicare Advantage members.

News for Humana Stock (HUM)